| Literature DB >> 26656911 |
Johann Edge1,2, Toby Mündel2, Henriette Pilegaard3, Emma Hawke3, Murray Leikis4, Nicolas Lopez-Villalobos5, Rodrigo S F Oliveira6, David J Bishop6.
Abstract
Minimizing the decrease in intracellular pH during high-intensity exercise training promotes greater improvements in mitochondrial respiration. This raises the intriguing hypothesis that pH may affect the exercise-induced transcription of genes that regulate mitochondrial biogenesis. Eight males performed 10x2-min cycle intervals at 80% VO2speak intensity on two occasions separated by ~2 weeks. Participants ingested either ammonium chloride (ACID) or calcium carbonate (PLA) the day before and on the day of the exercise trial in a randomized, counterbalanced order, using a crossover design. Biopsies were taken from the vastus lateralis muscle before and after exercise. The mRNA level of peroxisome proliferator-activated receptor co-activator 1α (PGC-1α), citrate synthase, cytochome c and FOXO1 was elevated at rest following ACID (P<0.05). During the PLA condition, the mRNA content of mitochondrial- and glucose-regulating proteins was elevated immediately following exercise (P<0.05). In the early phase (0-2 h) of post-exercise recovery during ACID, PGC-1α, citrate synthase, cytochome C, FOXO1, GLUT4, and HKII mRNA levels were not different from resting levels (P>0.05); the difference in PGC-1α mRNA content 2 h post-exercise between ACID and PLA was not significant (P = 0.08). Thus, metabolic acidosis abolished the early post-exercise increase of PGC-1α mRNA and the mRNA of downstream mitochondrial and glucose-regulating proteins. These findings indicate that metabolic acidosis may affect mitochondrial biogenesis, with divergent responses in resting and post-exercise skeletal muscle.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26656911 PMCID: PMC4686080 DOI: 10.1371/journal.pone.0141317
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Participants ingested either ammonium chloride (0.15 g.kg-1, ACID) or placebo (0.15 g.kg-1, PLA) in four doses during the 24 h prior to the trial day.
An 8 min warm-up (5 min at 40% of peak power output, 3 min at 60% of peak power output) was followed by 10 x 2 min intervals at 80% of peak power output, interspersed with 1 min of active rest at 40% of peak power output, performed on a cycle ergometer. Timings of additional supplementation, venous blood and muscle biopsy samples and a post-exercise meal are shown prior to and following the high-intensity interval session.
Primer and TAQMAN probe sequences used for real-time PCR.
PDK4, pyruvate dehydrogenase kinase 4; PGC-1α, peroxisome proliferator-activated receptor-γ coactivator-1α CS, citrate synthase; Cyt c, cytochrome c oxidase, HKII, hexokinase II; GLUT4, glucose transporter-4; PGC-1β, peroxisome proliferator-activated receptor gamma coactivator-1β FOXO1, forkhead box O1.
| Gene | Primer sequence (forward and reverse) | TaqMan Probe |
|---|---|---|
|
| 5'-TCCACTGCACCAACGCCT-3' | 5'-ATAATTCCCGGAATGCTCCTTTGGCTG-3' |
| 5'-TGGCAAGCCGTAACCAAAA-3' | ||
|
| 5’-CAAGCCAAACCAACAACTTTATCTCT-3’ | 5’-AGTCACCAAATGACCCCAAGGGTTCC-3’ |
| 5’-CACACTTAAGGTGCGTTCAATAGTC-3’ | ||
|
| 5’-GACTACATCTGGA ACACACTCAACTCA-3' | 5'-ACGGGTTGTTCCAGGCTATGGCCA-3' |
| 5'-CGCGGATCAGTCTTCCTTAGTAC-3' | ||
|
| 5'-GGTCTCTTTGGGCGGAAGAC-3’ | 5'-CCCTGGATACTCTTACACAGCCGCCAA-3' |
| 5' CTCTCCCCAGATGATGCCTTT 3’ | ||
|
| 5'-TTGTCCGTAACATTCTCATCGATT-3' | 5'-ACCAAGCGTGGACTGCTCTTCCGA-3' |
| 5'-TGTCTTGAGCCGCTCTGAGAT-3' | ||
|
| 5'-CCTGCCAGAAAGAGTCTGAAGC-3' | 5'-CAGAAACATCGGCCCAGCCTGTCA-3' |
| 5'-ATCCTTCAGCTCAGCCAGCA-3’ | ||
|
| 5'-GAGGGCTCCGGCACTTCT-3' | 5'-CCCAGATACACTGACTACGATTCCAATTCAGAAG-3' |
| 5'-CATGGCTTCATACTTGCTTTTCC-3' | ||
|
| 5'-ACCGAACAGGATGATCTTGGA-3' | 5'-CCATCTGCCGCAAAGATGGCCTCTA-3' |
| 5'-TTGCTTATCTCAGACAGACTGGGTAA-3' |
Least squares means (and standard errors) for plasma pH (pH), bicarbonate (HCO3-) and lactate (Lac-) concentrations for placebo (PLA) and acidosis (ACID) trials at rest (REST), immediately after exercise (POST-EX) and 2 hours (2H) following exercise.
| Rest | Post-Ex | 2h | ||
|---|---|---|---|---|
|
| PLA | 7.385 (0.023) | 7.302 (0.021) | 7.396 (0.022) |
| ACID | 7.293 (0.022) | 7.184 (0.019) | 7.303 (0.021) | |
|
| PLA | 27.2 (1.2) | 20.3 (2.5) | 26.3 (1.4) |
| ACID | 17.4 (1.1) | 10.3 (0.) | 14.1 (1.1) | |
|
| PLA | 1.7 (0.2) | 8.3 (1.2) | 2.1 (0.4) |
| ACID | 1.4 (0.2) | 5.4 (0.7) | 2.0 (0.2) |
* Denotes significant difference from Rest value within the treatment (p < 0.05).
‡ Denotes significant difference from Post-Ex value within the treatment (p < 0.05).
† Denotes significant difference to PLA value within the time (p < 0.05).
Fig 2Gene expression responses to a high-intensity interval exercise bout (10 x 2 min at 80% peak power output, 1 min @ 40% of peak power output) after the ingestion of ammonium chloride (ACID) or placebo (PLA).
The total ingestion of each supplement was 0.15 g·kg-1 on the day of the exercise protocol, equaling that consumed on the day prior to the trial. (a) PGC-1α, (b) citrate synthase, (C) cytochrome C; (d) PGC-1β. # significantly different to placebo at same time point (P < 0.05); * significantly different to same ingested substance at rest (P < 0.05). Values are least square means ± 95% confidence limits.
Fig 3Gene expression responses to a high-intensity interval exercise bout (10 x 2 min @ 80% peak power output, 1 min @ 40% of peak power output) after the ingestion of ammonium chloride (ACID) or placebo (PLA).
The total ingestion of each supplement was 0.15 g·kg-1 on the day of the exercise protocol, equaling that consumed on the day prior to the trial. (a) HKII, (b) GLUT4, (C) PDK4; (d) FOXO1. # significantly different to placebo at same time point (P < 0.05); * significantly different to same ingested substance at rest (P < 0.05). Values are least square means ± 95% confidence limits.